It is also possible that antidepressant action is mediated by stabilizing the BDNF receptor tropomyosin receptor kinase B, rather than increasing the expression of BDNF protein itself [36], which could explain the inconsistency, at least in the case of MDD, and shows different pathways for psychotherapy-induced changes in the brain. This evidence concerns the gene BDNF and major depressive disorder.